OSAIC HOLDINGS, INC. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$746,690
+25.6%
19,547
+18.8%
0.00%0.0%
Q2 2023$594,734
+25.8%
16,457
+32.2%
0.00%0.0%
Q1 2023$472,897
-74.5%
12,449
-61.8%
0.00%
-75.0%
Q4 2022$1,854,211
+56.7%
32,616
+9.0%
0.00%
+33.3%
Q3 2022$1,183,000
-33.3%
29,924
-25.7%
0.00%
-25.0%
Q2 2022$1,774,000
+216.8%
40,300
+185.3%
0.00%
+300.0%
Q1 2022$560,000
-10.5%
14,125
-9.4%
0.00%0.0%
Q4 2021$626,000
-41.4%
15,589
-40.6%
0.00%
-50.0%
Q3 2021$1,068,000
+71.4%
26,263
+92.2%
0.00%
+100.0%
Q2 2021$623,000
+12.5%
13,662
+3.5%
0.00%0.0%
Q1 2021$554,000
-78.4%
13,202
-78.0%
0.00%
-85.7%
Q4 2020$2,569,000
+801.4%
60,125
+459.1%
0.01%
+600.0%
Q3 2020$285,000
-15.2%
10,754
-14.4%
0.00%0.0%
Q2 2020$336,000
+127.0%
12,557
+53.2%
0.00%0.0%
Q1 2020$148,0008,1990.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders